
Celltrion Named as Preferred Bidder for a Biologics Plant Acquisition in the U.S.
Celltrion announced on July 29 that it has been selected as the preferred bidder for a biologics manufacturing plant in the United States, outpacing two global pharmaceutical companies. This marks a major step toward securing a local production base in the …